|
[1]
|
Kawasaki, T. (1967) Acute Febrile Mucocutaneous Syndrome with Lymphoid Involvement with Specific Desquamation of the Fingers and Toes in Children. Arerugi, 16, 178-222. (In Japanese)
|
|
[2]
|
Rowley, A.H. and Shulman, S.T. (2018) The Epidemiology and Pathogenesis of Kawasaki Disease. Frontiers in Pediatrics, 6, Article No. 374. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
McCrindle, B.W., Rowley, A.H., Newburger, J.W., et al. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation, 135, e927-e999.
|
|
[4]
|
Onouchi, Y., Gunji, T., Burns, J.C., et al. (2008) ITPKC Functional Polymorphism Associated with Kawasaki Disease Susceptibility and Formation of Coronary Artery Aneurysms. Nature Genetics, 40, 35-42. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Onouchi, Y., Ozaki, K., Buns, J.C., et al. (2010) Common Variants in CASP3 Confer Susceptibility to Kawasaki Disease. Human Molecular Genetics, 19, 2898-2906. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Chang, C.J., Kuo, H.C., Chang, J.S., et al. (2013) Replication and Meta-Analysis of GWAS Identified Susceptibility Loci in Kawasaki Disease Confirm the Importance of B Lymphoid Tyrosine Kinase (BLK) in Disease Susceptibility. PLoS ONE, 8, e72037. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Khor, C.C., Davila, S., Breunis, W.B., et al. (2011) Genome-Wide Association Study Identifies FCGR2A as a Susceptibility Locus for Kawasaki Disease. Nature Genetics, 43, 1241-1246. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Kim, J.J., Yun, S.W., Yu, J.J., et al. (2017) A Genome-Wide Association Analysis Identifies NMNAT2 and HCP5 as Susceptibility Loci for Kawasaki Disease. Journal of Human Genetics, 62, 1023-1029. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Akca, U.K., Kesici, S., Ozsurekci, Y., et al. (2020) Kawasaki-Like Disease in Children with COVID-19. Rheumatology International, 40, 2105-2115. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Toubiana, J., Poirault, C., Corsia, A., et al. (2020) Kawasaki-Like Multisystem Inflammatory Syndrome in Children during the Covid-19 Pandemic in Paris, France: Prospective Observational Study. BMJ, 369, m2094. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Feeney, C.C., Ajagbe, O.A. and Suryadevara, M. (2021) Yersinia enterocolitica Infection Presenting as Incomplete Kawasaki Disease: 2 Cases and a Review of the Literature. Journal of the Pediatric Infectious Diseases Society, 10, 217-219. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Sakurai, Y. (2019) Autoimmune Aspects of Kawasaki Disease. The Journal of Investigational Allergology and Clinical Immunology, 29, 251-261. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Hara, T., Yamamura, K. and Sakai, Y. (2021) The Up-to-Date Pathophysiology of Kawasaki Disease. Clinical & Translational Immunology, 10, e1284. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Ming, L., Cao, H.L., Li, Q., et al. (2021) Red Blood Cell Distribution Width as a Predictive Marker for Coronary Artery Lesions in Patients with Kawasaki Disease. Pediatric Cardiology, 42, 1496-1503. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Marchesi, A., Rigante, D., Cimaz, R., et al. (2021) Revised Recommendations of the Italian Society of Pediatrics about the General Management of Kawasaki Disease. Italian Journal of Pediatrics, 47, 16. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
刘飞, 吴克义. 杭州市2014-2018年川崎病患儿流行病学调查及并发冠状动脉损害危险因素分析[J]. 中国公共卫生管理, 2020, 36(5): 631-635.
|
|
[17]
|
Li, J., Li, D.E., Hu, M., et al. (2021) Red Blood Cell Distribution Width and Tumor Necrosis Factor-α for the Early Prediction of Coronary Artery Lesion in Kawasaki Disease: A Retrospective Study. European Journal of Pediatrics. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Fabi, M., Andreozzi, L., Frabboni, I., et al. (2021) Non-Coronary Cardiac Events, Younger Age, and IVIG Unresponsiveness Increase the Risk for Coronary Aneurysms in Italian Children with Kawasaki Disease. Clinical Rheumatology, 40, 1507-1514. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
刘庚英, 汪顺雨, 杜忠东. N末端脑钠肽前体和脑钠肽对川崎病的诊断及并发冠状动脉损伤的早期预测价值[J]. 中国医学前沿杂志(电子版), 2021, 13(4): 87-91.
|
|
[20]
|
中华医学会儿科学分会心血管学组, 中华儿科杂志编辑委员会. 川崎病冠状动脉病变的临床处理建议(2020年修订版) [J]. 中华儿科杂志, 2020, 58(9): 718-724.
|
|
[21]
|
Zheng, X., Yue, P., Liu, L., et al. (2019) Efficacy between Low and High Dose Aspirin for the Initial Treatment of Kawasaki Disease: Current Evidence Based on a Meta-Analysis. PLoS ONE, 14, e0217274. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Jia, X., Du, X., Bie, S., et al. (2020) What Dose of Aspirin Should Be Used in the Initial Treatment of Kawasaki Disease? A Meta-Analysis. Rheumatology (Oxford), 59, 1826-1833. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Catella-Lawson, F., Reilly, M.P., Kapoor, S.C., et al. (2001) Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin. The New England Journal of Medicine, 345, 1809-1817. [Google Scholar] [CrossRef]
|
|
[24]
|
Gentilomo, C., Huang, Y.S. and Raffini, L. (2011) Significant Increase in Clopidogrel Use across U.S. Children’s Hospitals. Pediatric Cardiology, 32, 167-175. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Manlhiot, C., Newburger, J.W., Low, T., et al. (2020) Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children with Coronary Artery Aneurysms after Kawasaki Disease: A Pragmatic Registry Trial. Canadian Journal of Cardiology, 36, 1598-1607. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
How, C.H. (2015) Novel Oral Anticoagulants for Atrial Fibrillation. Singapore Medical Journal, 56, 657-658. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Mekaj, Y.H., Mekaj, A.Y., Duci, S.B., et al. (2015) New Oral Anticoagulants: Their Advantages and Disadvantages Compared with Vitamin K Antagonists in the Prevention and Treatment of Patients with Thromboembolic Events. Therapeutics and Clinical Risk Management, 11, 967-977. [Google Scholar] [CrossRef]
|
|
[28]
|
Blankier, S., McCrindle, B.W., Ito, S., et al. (2011) The Role of Atorvastatin in Regulating the Immune Response Leading to Vascular Damage in a Model of Kawasaki Disease. Clinical & Experimental Immunology, 164, 193-201. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Niedra, E., Chahal, N., Manlhiot, C., et al. (2014) Atorvastatin Safety in Kawasaki Disease Patients with Coronary Artery Aneurysms. Pediatric Cardiology, 35, 89-92. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Huang, S.M., Weng, K.P., Chang, J.S., et al. (2008) Effects of Statin Therapy in Children Complicated with Coronary Arterial Abnormality Late after Kawasaki Disease: A Pilot Study. Circulation Journal, 72, 1583-1587. [Google Scholar] [CrossRef]
|
|
[31]
|
Tremoulet, A.H., Jain, S., Jone, P.N., et al. (2019) Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm. The Journal of Pediatrics, 215, 107-117.e12. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
石琳, 林瑶, 邓燕俊, 等. 川崎病抗凝治疗的指征及应用[J]. 中国实用儿科杂志, 2017, 32(8): 588-591.
|
|
[33]
|
崔青, 沈捷. 川崎病冠状动脉病变的手术治疗[J]. 中华实用儿科临床杂志, 2021, 36(10): 789-793.
|
|
[34]
|
Harada, M., Akimoto, K., Ogawa, S., et al. (2013) National Japanese Survey of Thrombolytic Therapy Selection for Coronary Aneurysm: Intracoronary Thrombolysis or Intravenous Coronary Thrombolysis in Patients with Kawasaki Disease. Pediatrics International, 55, 690-695. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Jeong, D.S., Han, W., Lee, Y.T., et al. (2018) Coronary Artery Bypass Grafting with Arterial Grafts in Patients with Kawasaki Disease Affecting the Coronary Artery: A Korean Single-Center Study. Journal of Korean Medical Science, 33, e267. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
项云, 程自平, 程景林, 等. 雷帕霉素洗脱支架植入治疗川崎病冠状动脉完全闭塞性病变一例[J]. 中华儿科杂志, 2020, 58(2): 145-147.
|
|
[37]
|
Komarov, R., Ismailbaev, A., Chragyan, V., et al. (2020) State-of-the-Art Pediatric Coronary Artery Bypass Surgery: A Literature Review. Brazilian Journal of Cardiovascular Surgery, 35, 539-548. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Salsano, A., Liao, J., Miette, A., et al. (2021) Surgical Myocardial Revascularization Outcomes in Kawasaki Disease: Systematic Review and Meta-Analysis. Open Medicine (Warsaw, Poland), 16, 375-386. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Matsumoto, Y., Fukushima, S., Shimahara, Y., et al. (2020) Robotic Minimally Invasive Direct Coronary Artery Bypass for Kawasaki Disease. General Thoracic and Cardiovascular Surgery, 68, 1037-1039. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
孙国成, 易定华, 郑奇军, 等. 川崎病巨大冠状动脉瘤的外科治疗(附5例报告) [J]. 解放军医学杂志, 2008, 33(7): 871-872.
|
|
[41]
|
郭青, 刘洁, 蔡杰, 等. 川崎病巨大冠状动脉瘤心脏移植一例[J]. 中华儿科杂志, 2019, 57(3): 224-226.
|
|
[42]
|
熊祎, 张永兰, 杜忠东. 川崎病合并巨大冠状动脉瘤101例中长期随访[J]. 中华儿科杂志, 2021, 59(2): 101-106.
|